PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel …

San Bruno, CA. (PRWEB) March 04, 2015

PRC Clinical, a full-service, Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, will exhibit and present at the Outsourcing in Clinical Trials (OCT) Israel Conference 2015 on March 25th and 26th in Tel Aviv, Israel.

PRC Clinical seeks to build relationships with Israeli life science companies seeking to conduct U.S. Food and Drug Administration (FDA) clinical trials. The companys services span all phases of human trials, from Phase I studies in healthy subjects, through to Phase II, dose-finding and safety studies to larger Phase III and post-marketing studies.

Israel is one of the major emerging markets in terms of healthcare and pharmaceuticals worldwide. According to the Israeli Ministry of Economy, Israel is the fourth largest supplier of pharmaceutical products to the U.S. market. We are familiar with the Israeli and U.S. drug development industry and regulatory requirements, said Tony Taricco, President and Chief Operating Officer at PRC Clinical. We have significant CRO experience conducting trials from early phase through to regulatory submission across a wide range of different therapeutic areas.

PRC Clinical will present its clinical services at the event, along with its partner, Statistics & Data Corporation (SDC). SDC offers biostatistics and clinical data management services to pharmaceutical, biotechnology, medical device companies, and CROs. Our strategic alliance with SDC allows us to offer best-in-class, full-service solutions to better meet the clinical trial needs of Israeli sponsors, said Curtis Head, Chief Executive Officer at PRC Clinical.

The company has the experience and regulatory knowledge to support Israeli sponsors planning to conduct US-based clinical trials. Last year, BrainStorm Cell Therapeutics, an Israel-based biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, engaged PRC Clinical as its CRO to support its ongoing U.S. clinical program. PRC Clinical was selected based on the companys strong experience conducting orphan drug trials in neurology, specifically in the area of amyotrophic lateral sclerosis (ALS).

If you would like to arrange to meet with a PRC Clinical representative at the OCT Israel Conference in Tel Aviv, please contact us at info(at)prcclinical(dot)com.

About PRC Clinical

PRC Clinical is a full-service CRO headquartered in the San Francisco Bay Area offering clinical trial- management services to drug and medical device sponsors. PRC delivers the highest quality results in the industry, and has the capabilities and expertise to handle the most complex clinical trials. PRC has served sponsors in all phases of clinical studies from orphan drug trials to large clinical registries globally. We are therapeutically diverse and experienced with innovative treatment modalities from regenerative stem-cell technologies to cutting-edge medical devices. Services include clinical operations, project and site management, regional monitoring, medical and safety monitoring, Eclipse clinical payment services, CTMS, protocol design and development, IND preparation and filing, clinical laboratory services, medical writing, and consulting. For more information, call (877-519-6001) or e-mail info(at)prcclinical(dot)com.

About Statistics & Data Corporation (SDC)

More here:
PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel ...